- 1、本文档被系统程序自动判定探测到侵权嫌疑,本站暂时做下架处理。
- 2、如果您确认为侵权,可联系本站左侧在线QQ客服请求删除。我们会保证在24小时内做出处理,应急电话:400-050-0827。
- 3、此文档由网友上传,因疑似侵权的原因,本站不提供该文档下载,只提供部分内容试读。如果您是出版社/作者,看到后可认领文档,您也可以联系本站进行批量认领。
查看更多
摩根大通-146页英文-中国医疗业希望和机会
Asia Pacific Equity Research
15 October 2011
China Healthcare
Shattered landscape; hope and opportunity
Sell-off creating buying opportunities: The MSCI China healthcare index Healthcare
(down 13.5% in the past three months and 2 % YTD) is trading at the AC
Sean Wu
lowest multiples since mid-2009, with many counters offering enticing
(852) 2800 8538
valuations when set against the growth prospects, in our view. We believe sean.wu@
the sentiment has been too negative given that the secular growth of
J.P. Morgan Securities (Asia Pacific) Limited
healthcare industry looks intact and it is in the government’s interest to
strengthen, not weaken, the domestic players. We are confident that many
healthcare companies can withstand short-term negative macro headwinds
and emerge with growth outlooks intact. We believe the recent sell-off has
created some attractive buying opportunities. One-year China APxJ Healthcare
Fundamentals for long-term growth look strong - underpinned by 20%
文档评论(0)